Related Products
|
||||||
About
EquiReason is an equity research and market-intelligence platform for self-directed investors, independent analysts and research teams. It combines SEC company filings, XBRL financial data, earnings-call transcripts and market information to help users examine financial performance, ownership activity, trends and company exposure. The platform traces market events through economic mechanisms to potentially affected companies and presents each company verdict with supporting and counter-evidence. Research views include financial statements, valuation context, insider and institutional activity, segment revenue data, company-specific measures and alerts, with evidence linked to its underlying source. EquiReason is available through the web and an iPhone app, with a free plan and paid research tiers. It provides research and decision support, not investment advice.
|
About
FN2 is an autonomous stock decision engine. Instead of you running the same research loop every morning, FN2 dispatches AI agents that watch the markets, do the deep research on a schedule, and deliver the answer to your Inbox, Phone, or Discord.
Describe what you want to track in natural language: A ticker, a sector, a thesis, or a question like "alert me when NVDA's guidance changes" or pick a pre-built agent. FN2 turns it into an autonomous research agent that runs on your schedule: before the open, right after earnings, or weekly. Each agent reads earnings-call transcripts, pulls FRED macro data, screens tickers, builds charts, and reasons over all of it — then delivers a decision-ready brief, not a pile of raw data. No tabs, no screeners, no manual morning research. Built for serious individual investors and analysts who are drowning in tabs, transcripts, and screeners doing the same work by hand every day.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
Self-directed stock investors, independent analysts, finance writers and small research teams covering US equities
|
Audience
Individual investors, retail traders, financial analysts, RIAs, and finance professionals
|
|||||
Support
Phone Support
Not Supported
24/7 Live Support
Not Supported
Online
Not Supported
|
Support
Phone Support
Not Supported
24/7 Live Support
Not Supported
Online
Supported
|
|||||
API
Offers API
Supported
|
API
Offers API
Not Supported
|
|||||
Screenshots and VideosNo images available
|
Screenshots and VideosNo images available
|
|||||
Pricing
$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Version
Supported
Free Trial
Supported
|
Pricing
$30/month
Free Version
Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Not Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Not Supported
|
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Not Supported
|
|||||
Company InformationEquiReason
Founded: 2026
Turkey
equireason.com
|
Company InformationFN2
Founded: 2026
United States
fn2.ai
|
|||||
AlternativesNo Alternatives
|
Alternatives |
|||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
No info available.
|
Integrations
No info available.
|
|||||
|
|
|